People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement on the first day the new $2,000 annual out-of-pocket spending cap for prescription ...
A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
In “5 Things to Know This Week,” changes coming to Medicare Part D in 2025,plus sales to find in January and other stories from the week.
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
As KFF noted in a report earlier this year, more than 1.5 million Medicare Part D enrollees had annual out-of-pocket costs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback